• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection From 2015 to 2019 in a Cohort of Adults With

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2025 Mar 14;12(4):ofaf166.
doi: 10.1093/ofid/ofaf166. eCollection 2025 Apr. Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection From 2015 to 2019 in a Cohort of Adults With High-risk Conditions

Maria E Sundaram[SUP] 1 [/SUP], David L McClure[SUP] 1 [/SUP], Oluwakemi Alonge[SUP] 1 [/SUP], Elisha Stefanski[SUP] 2 [/SUP], Pouya Saeedi[SUP] 3 [/SUP], Jean-Yves Pirçon[SUP] 3 [/SUP], Huong Q Nguyen[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Adults with high-risk conditions (underlying health conditions that increase risk of severe outcomes after respiratory infection) may have a substantial incidence of respiratory syncytial virus (RSV), but existing information on this topic is limited. We assessed the seasonal incidence of RSV in adults with high-risk conditions in a Wisconsin community.
Methods: We conducted a retrospective study using data and respiratory specimens from participants with medically attended acute respiratory illness (MAARI) in a test-negative study of influenza vaccine effectiveness. We included individuals ≥18 years old in 2015-16 through 2019-20 seasons, with ≥1 high-risk condition. Residual respiratory specimens were retested for RSV using a multiplex viral panel. We calculated seasonal incidence using Poisson regression and population weighting, with the sum of observed and extrapolated RSV cases in the study cohort divided by the number of adults with high-risk conditions in the underlying source population.
Results: Of 3601 respiratory samples tested, 97% were White and 66% were female. The mean (standard deviation) age of participants was 53 (19) years. We identified 303 RSV infections; 40% were RSV A. Estimated incidence of RSV-related MAARI was 94.1 (79.5-111.5) per 10 000 high-risk adults across all seasons and varied by season. Age-specific incidence per 10 000 was 69.3 (95% confidence interval [CI], 52.4-91.7) for those 18-49 years; 131.6 (95% CI, 92.3-187.6) for those 50-59 years; 109.9 (95% CI, 80.2-150.6) for those 60-74 years; and 150.5 (95% CI, 100.8-224.6) for those ≥75 years.
Conclusions: Overall, these findings suggest a substantial incidence of RSV-related MAARI in adults with high-risk conditions.

Keywords: RSV; adults; community burden; high risk; incidence; medically attended; viral epidemiology.

 
Back
Top Bottom